About

About AsymBio Asymchem (Stock Code: 002821.SZ/6821.HK) is a global leading CDMO founded in 1995, offering integrated solutions across the pharmaceutical lifecycle—from R&D to commercial production. Specializing in small molecules, chemical macromolecules, biologics, and synthetic biology, Asymchem operates R&D and manufacturing facilities in China, the U.S., and the U.K., supported by a team of over 9,000 professionals . Its subsidiary, AsymBio, is committed to being a technology-driven CDMO with a global vision and best-in-class solutions for bioconjugates, antibodies, etc. With a proven track record, AsymBio is the innovative, reliable and client centric CDMO partner driven for your success in the competitive pharmaceutical landscape